Clinical Trial Update: Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether fosaprepitant affects motor evoked and somatosensory evoked potentials under general anesthesia in postoperative nausea patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

Sponsor: Stanford University | Conditions: Postoperative Nausea | Phase 4 | Status: COMPLETED | Results posted: 2022-07-18